Interestingly, an inflammatory marker analysis of neonatal blood reported that children who developed pre-B ALL had a cytokine signature (lower concentrations of the cytokine IL-8, soluble IL-6 receptor α, and TGF-β1 and higher concentrations of IL-6, IL-17, and IL-18) (129). The gene discussed is IL6; the disease is acute lymphoblastic leukemia.